|Ref. Number :||29457496|
|Requirement :||Conclusion of a non-inclusive discount agreement according to § 130a Abs. 8 SGB V on the active ingredient Abacavir, J05AF06, for the period 1.7.2018 - 30.6.2020.<br />Section 130a (8) SGB V allows health insurance companies and pharmaceutical companies to conclude framework discount agreements on medicines to be paid to the statutory health insurance funds. In view of the pertinent statutory provisions on the award of public contracts, a regular process of active substance-related, formal award procedures takes place according to the regulations of the 4th part of the GWB by the DAK-G. For medicinal products for the active substance abacavir, J05AF06, to be designated by the tenderer in Annex 2 to the contract, DAK-G intends to conclude drug discount agreements with as many interested pharmaceutical companies as possible before the entry into force of new drug rebate contracts. A discount contract within the scope of the approval model for the o.g. Active ingredient will enter into force on 1.7.2018 and will end on 30.6.2020. It automatically ends independently with the entry into force of the exclusive contract.|
|Tender Estimated Cost :||EUR 1|
|Closing Date :||05/05/2020|
|Location :||Not Classified - Not Classified - Germany|
Subscribe our annual Project Alert Service and get access to all similar Tenders.If you are registered member, please fill in the subscription form below . If not, please Register first.